Nurix CSO sells 1,452 shares after option exercise
After exercising options under a Rule 10b5-1 plan, Hansen still held 60,858 stock options expiring Aug. 28, 2029.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. (NRIX) reported that Chief Scientific Officer Gwenn Hansen exercised employee stock options for 1,452 shares of common stock at an exercise price of $1.86 per share and on the same date sold 1,452 shares at $25.47 per share. Following the option exercise, Hansen held 60,858 stock options directly, expiring on August 28, 2029. The transactions were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Insider Trade Summary 10b5-1
Exercise and Sale: 1,452 shares ($34K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Hansen Gwenn
Role
Chief Scientific Officer
Sold
1,452 shs ($37K)
Approx. gross sale proceeds
$37K
Approx. exercise cost
$3K
Approx. pre-tax spread
$34K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F1, F2 | 1,452 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,452 | $1.86 | $3K |
| Sale | Common Stock F1 | 1,452 | $25.47 | $37K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 60,858 contracts (Direct);
Common Stock — 117,227 shares (Direct)
Footnotes (2)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. The stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023.
Key Figures
Options exercised: 1,452 shares
Option exercise price: $1.86 per share
Sale price: $25.47 per share
+4 more
7 metrics
Options exercised
1,452 shares
Employee stock options exercised into common stock on September 1, 2026
Option exercise price
$1.86 per share
Exercise price for employee stock options converted into common stock
Sale price
$25.47 per share
Price for sale of 1,452 shares of common stock on September 1, 2026
Shares sold
1,452 shares
Common stock sold in a code “S” transaction on September 1, 2026
Options remaining after transaction
60,858 options
Total employee stock options held directly after the reported exercise
Option expiration date
August 28, 2029
Expiration date for the employee stock option involved in the exercise
Vesting schedule fraction
1/48 of total shares monthly
Vesting pattern from June 10, 2019 until fully vested on May 10, 2023
Key Terms
Rule 10b5-1 trading plan, Employee Stock Option, derivative security, beneficial ownership
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option financial
"security_title: Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
beneficial ownership financial
"disclaims beneficial ownership except to the extent of any pecuniary intere"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NRIX’s Chief Scientific Officer report on this Form 4?
The Chief Scientific Officer, Gwenn Hansen, exercised employee stock options for 1,452 shares of Nurix Therapeutics common stock at $1.86 per share and sold 1,452 shares of common stock at $25.47 per share on September 1, 2026.
Were the NRIX insider transactions made under a Rule 10b5-1 trading plan?
Yes. The filing states that the reported transactions were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating the trades were pre-arranged under that plan.
How many NRIX employee stock options did the insider exercise and at what price?
The insider exercised 1,452 employee stock options to acquire Nurix Therapeutics common stock at an exercise price of $1.86 per share. These options were fully vested as of May 10, 2023 according to the vesting footnote.
How many NRIX stock options does the insider hold after these transactions?
After the option exercise, the reporting person held 60,858 employee stock options directly. These options relate to Nurix Therapeutics common stock and have an expiration date of August 28, 2029.
What is the vesting schedule disclosed for the exercised NRIX stock options?
The filing notes that the stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023.
AI-generated analysis. How Rhea-AI works. Not financial advice.
